Giuseppe Granata

Title: Giuseppe Granata: Innovator in Ocular Disease Treatment

Introduction

Giuseppe Granata is a notable inventor based in Acireale, Italy. He has made significant contributions to the field of ocular disease treatment through his innovative research and patent work. His expertise lies in developing advanced formulations that enhance the delivery of active ingredients for therapeutic purposes.

Latest Patents

Giuseppe Granata holds a patent for "Nanostructured formulations for the delivery of silibinin and other active ingredients for treating ocular diseases." This patent describes formulations that incorporate silibinin or other active ingredients within lipid nanoparticle systems, specifically of the SLN and NLC types. These formulations are based on calixarenes and may possess mucoadhesive properties. They are designed for use in treating neurodegenerative ocular diseases. The versatility of the calixarene compound is highlighted, as it can charge and release active ingredients characterized by low water solubility, easy chemical and enzymatic degradation, and low bioavailability.

Career Highlights

Giuseppe Granata is associated with the Distretto Tecnologico Sicilia Micro E Nano Sistemi S.c.a.r.l., where he continues to advance his research in nanotechnology and ocular treatments. His work is pivotal in bridging the gap between innovative science and practical medical applications.

Collaborations

Giuseppe collaborates with esteemed colleagues, including Anna Rita Blanco and Maria Luisa Bondi. Their combined efforts contribute to the development of cutting-edge solutions in the field of ocular health.

Conclusion

Giuseppe Granata's innovative work in nanostructured formulations represents a significant advancement in the treatment of ocular diseases. His contributions are vital for improving therapeutic outcomes and enhancing the quality of life for patients suffering from these conditions.